Industry Insights

  1. The One Moment You Have Leverage In A Clinical Trial, And Why It Disappears Fast 8/13/2026

    Discover how to maintain strategic leverage during vendor selection. Learn to identify flexible, long-term partners who keep clinical trials on track before contracts are signed.

  2. No-Frills, High-Impact Vendor Oversight: 4 Principles That Never Let Me Down 8/13/2026

    Discover a streamlined four-pillar framework for vendor oversight. Learn how tracking essential KPIs across time, budget, quality, and relationships drives accountability in clinical operations.

  3. Killing Excel: The Quiet Crisis In Clinical Trials 8/13/2026

    Stop relying on spreadsheets for critical clinical trial decisions. Learn how standardizing vendor selection eliminates inefficiencies and protects budgets.

  4. Keep Your Vendors On Track: The 4 KPIs That Matter Most 8/13/2026

    Master clinical vendor management with four key pillars: time, money, quality, and relationships. Learn which essential KPIs keep your trial timelines and budgets on track.

  5. Mastering Clinical Trial Forecasting Through Continuous Learning 8/13/2026

    Stop treating trial budgets as fixed predictions. Discover how top teams refine financial forecasts by tracking shifting assumptions to improve governance and build trust.

  6. Cagey Sponsors, Defensive Vendors: Observations On How Transparency Breaks Down 8/13/2026

    Discover how hidden operational uncertainties trigger defensive pricing and scope disputes—and how early transparency builds stable, high-performing research partnerships.

  7. A System For Better Vendor Relationships 8/13/2026

    Shift your clinical trial strategy with zero-cost habits that build trust, protect trial continuity, and transform routine supplier management into resilient, high-performing partnerships.

  8. When Early CRO Wins Quietly Create Long-Term Study Risk 8/13/2026

    Discover how overemphasizing early trial milestones can compromise long-term execution. Learn key strategies to build sustainable operational frameworks for lasting study success.

  9. The Patient Advocacy Strategy Behind Skyhawk's Rapid Enrollment 8/13/2026

    Skyhawk’s patient-first approach shows how advocacy partnerships, site engagement, and operational quality can accelerate enrollment without losing focus on patients.

  10. What The FDA's Latest Move On Psychedelics Means For Non-Hallucinogenic Drug Sponsors 8/13/2026

    Taking another angle to the FDA focus on psychedelic research, Enveric Biosciences CEO Joseph Tucker, Ph.D., explores what the FDA’s moves mean for non-hallucinogenic drug sponsors.